The United States says it is escalating the war against Iran, reducing the likelihood of negotiations between the two sides
Svmuu News U.S. officials stated that military actions against Iran are escalating, with little possibility of diplomatic negotiations, which undoubtedly pours cold water on President Trump's claim that the conflict might be resolved soon. U.S. Special Envoy for the Middle East, Witkoff, said that U.S. leaders are always willing to engage in dialogue but simultaneously expressed skepticism about Iran's willingness to talk. "The questions we are raising today are the same as those we raised when we negotiated with them before—whether they genuinely wish to resolve this issue through diplomatic means," Witkoff stated. "So far, all signs indicate that the answer is no." The U.S. Department of Defense reiterated this message earlier in the day, stating that the United States and Israel are launching the most intense attacks against Iran to date and will not give up until Iran is completely defeated, which is more aggressive than Trump's remarks on Monday. (Jin10)
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
3
Will the BEAM token go to zero? Could it rise to $1,000? An in-depth analysis of the Beam network and its market prospects
-
4
The analysis points out that Iran’s overlapping centers of power complicate efforts to end the war with the United States, and that the Revolutionary Guards possess significant operational autonomy.
-
5
Israeli West Bank Settler Tells BBC Attacks on Palestinians Are Justified as Revenge, Equating One Jewish Life to "10 Million" Palestinians
-
6
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
7
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
8
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
9
Analysis Compares Healthcare ETFs: Invesco Nasdaq Biotech ETF (IBBQ) Saw 45.5% One-Year Return, Outperforming State Street Healthcare Select Sector SPDR ETF (XLV)
-
10
Analysis: Vanguard Small-Cap Growth ETF (VBK) up 21% YTD 2026, Outperforming Large-Cap Growth ETF (VONG) at 0.3% YTD
Markets Today
Recommended Reading






